东宝生物
(300239)
| 流通市值：33.56亿 | | | 总市值：33.78亿 |
| 流通股本：5.90亿 | | | 总股本：5.94亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 369,055,800.99 | 188,034,307.73 | 884,932,215.88 | 633,112,065.92 |
| 营业收入 | 369,055,800.99 | 188,034,307.73 | 884,932,215.88 | 633,112,065.92 |
| 二、营业总成本 | 327,726,411.88 | 165,982,769.88 | 784,300,105.92 | 555,269,833.32 |
| 营业成本 | 275,176,850.03 | 140,917,714.68 | 683,859,412.69 | 489,880,095.68 |
| 税金及附加 | 5,389,593.69 | 2,601,869.28 | 9,809,271.24 | 6,864,108.18 |
| 销售费用 | 9,435,417.36 | 3,973,926.36 | 18,695,645.02 | 12,635,523.41 |
| 管理费用 | 24,413,751.7 | 12,990,219.57 | 49,965,485.13 | 33,584,181.69 |
| 研发费用 | 12,476,486.44 | 5,722,250.85 | 27,361,788.76 | 16,012,452.92 |
| 财务费用 | 834,312.66 | -223,210.86 | -5,391,496.92 | -3,706,528.56 |
| 其中:利息费用 | 2,268,836.6 | 726,987.63 | 2,564,535.38 | 1,959,679.91 |
| 其中:利息收入 | 1,343,190.4 | 831,304.14 | 7,114,485.65 | 5,517,789.65 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -1,566,045.78 | -576,059.12 | -3,743,341.08 | -3,007,719.11 |
| 资产处置收益 | -90,612.61 | 10,571.31 | -284,115.61 | -277,943.39 |
| 资产减值损失(新) | -3,128,326.29 | -1,519,552.08 | -3,316,535.41 | -1,548,347.56 |
| 信用减值损失(新) | 336,794.19 | 137,864.54 | 525,527.93 | 552,636.23 |
| 其他收益 | 5,144,013.21 | 2,188,036.21 | 12,367,917.13 | 9,035,682.43 |
| 四、营业利润 | 42,025,211.83 | 22,292,398.71 | 106,181,562.92 | 82,596,541.2 |
| 加:营业外收入 | 413,287.68 | 142,580.56 | 341,822.39 | 116,706.7 |
| 减:营业外支出 | 37,161.13 | 1,907.09 | 890,408.01 | 890,452.41 |
| 五、利润总额 | 42,401,338.38 | 22,433,072.18 | 105,632,977.3 | 81,822,795.49 |
| 减:所得税费用 | 5,434,215.23 | 3,388,371.44 | 14,368,848.66 | 10,287,606.93 |
| 六、净利润 | 36,967,123.15 | 19,044,700.74 | 91,264,128.64 | 71,535,188.56 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 36,967,123.15 | 19,044,700.74 | 91,264,128.64 | 71,535,188.56 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 36,967,330.23 | 19,044,819.05 | 85,982,726.28 | 66,273,700.7 |
| 少数股东损益 | -207.08 | -118.31 | 5,281,402.36 | 5,261,487.86 |
| 扣除非经常损益后的净利润 | 33,435,102.1 | 17,761,653.62 | 79,089,272.16 | 59,197,537.32 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.06 | 0.03 | 0.14 | 0.11 |
| (二)稀释每股收益 | 0.06 | 0.03 | 0.13 | 0.1 |
| 九、综合收益总额 | 36,967,123.15 | 19,044,700.74 | 91,264,128.64 | 71,535,188.56 |
| 归属于母公司股东的综合收益总额 | 36,967,330.23 | 19,044,819.05 | 85,982,726.28 | 66,273,700.7 |
| 归属于少数股东的综合收益总额 | -207.08 | -118.31 | 5,281,402.36 | 5,261,487.86 |
| 公告日期 | 2025-08-29 | 2025-04-24 | 2025-04-24 | 2024-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |